Bottom line
What is PSIAX's expense ratio?
PSIAX's expense ratio is 0.51%, or about $51 a year on every $10,000 invested. That is cheaper than 76% of large blend funds we track (median 0.83%). This share class also charges a front-end sales load of up to 3.25%, taken from your investment when you buy. Its expense ratio includes a 0.3% 12b-1 marketing fee.
Updated Nov 25, 2025
PSIAX fee table
| Net expense ratio | 0.51% |
|---|---|
| Gross expense ratio | 0.58% |
| Management fee | 0.15% |
| 12b-1 (distribution) fee | 0.3% |
| Other expenses | 0.13% |
| Fee waiver / reimbursement | -0.07% |
| Max front-end sales load | 3.25% |
| Max deferred sales charge | 1% |
| Redemption fee | 0% |
Source: Fund prospectus fee table, filed Nov 25, 2025
What PSIAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| PSIAX | $375 | $498 | $632 | $1,021 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.51% expense ratio costs roughly $29,500 in lost growth, versus about $46,700 for the median large blend fund (0.83%).
Cheaper alternatives to PSIAX
These funds have a similar portfolio (by top-holdings overlap) and a lower expense ratio. Savings are per $10,000 invested.
*Difference in ending value of $10,000 after 20 years at a 6% gross annual return, net of each fund's expense ratio.